Table 5.
Questionnaire of knowledge towards COVID-19
| Questions | n (%) Correct answer | |
| 1 | COVID-19 is also known as SARS-CoV-2. | 361(59%) |
| 2 | Coronavirus is the causative organism responsible for MERS (Middle East respiratory syndrome), SARS (severe acute respiratory syndrome) and COVID-19. | 414 (67.6%) |
| 3 | In COVID-19, the Chinese horseshoe bats are the most probable origin. | 187 (30.6%) |
| 4 | Does COVID-19 has any intermediate host? | 183(29.9%) |
| 5 | COVID-19 can be transmitted by close contact with infected person or animal. | 507 (82.8%) |
| 6 | COVID-19 can be transmitted from respiratory droplets and physical contact. | 540(88.2%) |
| 7 | COVID-19 incubation period is 1–14 days. | 582 (95.1%) |
| 8 | The main clinical symptoms of COVID-19 are fever, dry cough and shortness of breath. | 608 (99.1%) |
| 9 | Patients with COVID-19 cannot infect others when a fever is not present. | 15(2.5%) |
| 10 | Isolation and treatment are effective ways to reduce the spread of infection in patients with COVID-19. | 606 (99%) |
| 11 | Individuals should avoid going to crowded places such as airports, train stations and avoid taking public transportations. | 607 (99.2%) |
| 12 | People who have contact with COVID-19 patient should be immediately isolated in a proper place for at least 14 days. | 605 (98.9%) |
| 13 | It is important to stay 6 feet away from a person who is infected with COVID-19. | 486 (79.4%) |
| 14 | Presently, there is no effective treatment for COVID-19, but early symptomatic and supportive care can help most patients recover from the infection. | 550(88.9%) |
| 15 | Antibiotics can be used as first line of treatment. | 335 (54.7%) |
| 16 | COVID-19 does not develop to severe cases in all patients. Elderly patients with chronic illnesses, are more likely to be serious cases. | 475 (77.6%) |
| 17 | As per guidelines from health authorities, washing hands with soap and water for at least 20 s can help in prevention of COVID-19. | 484 (79.1%) |
| 18 | PCR is used to diagnose COVID-19. | 270 (44.1%) |
| 19 | COVID-19 vaccines are available in the market. | 583 (95.3%) |
COVID-19, coronavirus disease 2019; PCR, polymerase chain reaction; SARS-CoV-2, severe acute respiratory syndrome–coronavirus-2.